In This Article:
The most recent trading session ended with BellRing Brands (BRBR) standing at $72.48, reflecting a -0.12% shift from the previouse trading day's closing. The stock trailed the S&P 500, which registered a daily gain of 0.16%. Meanwhile, the Dow gained 0.25%, and the Nasdaq, a tech-heavy index, lost 0.06%.
Shares of the nutritional supplements company have depreciated by 6.16% over the course of the past month, underperforming the Medical sector's loss of 5.31% and the S&P 500's loss of 2.7%.
The investment community will be closely monitoring the performance of BellRing Brands in its forthcoming earnings report. The company is scheduled to release its earnings on February 3, 2025. The company's earnings per share (EPS) are projected to be $0.47, reflecting a 9.3% increase from the same quarter last year. In the meantime, our current consensus estimate forecasts the revenue to be $522.09 million, indicating a 21.3% growth compared to the corresponding quarter of the prior year.
For the full year, the Zacks Consensus Estimates are projecting earnings of $2.16 per share and revenue of $2.29 billion, which would represent changes of +11.92% and +14.78%, respectively, from the prior year.
Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for BellRing Brands. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. BellRing Brands is currently a Zacks Rank #2 (Buy).
Investors should also note BellRing Brands's current valuation metrics, including its Forward P/E ratio of 33.53. This valuation marks a premium compared to its industry's average Forward P/E of 18.88.
One should further note that BRBR currently holds a PEG ratio of 2.44. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Medical - Products industry had an average PEG ratio of 2.1 as trading concluded yesterday.